What a good shareholding pattern👌

Look at the kind of FIIs and DIIs holding the comp

Dream names🙂

Jubilant ingrevia
#jubilantingrea

Equirus initiates with target of 1,013rs

Expects the specialty chem to drive the growth
Lowest cost producer of pyridine derivatives with 20-80% mkt share

Nutrition n health science to grow steadily

Big volume growth expctd

Capex beneficiary

Caustic soda,sodaash,acetic anhydride,ethyl acetate,acetic acid,sodium bicarbonate
These prices are seeing an excellent uptick

Caustic soda n sodaash especially,rising on a daily basis

Beneficiaries:
Guj alkalies
DCM
DCW
Chemplast
Jubilant ingrevia
GHCL
GNFC
Tata chemicals
GSFC

Jubilant ingrevia
#jublingrea

Investment of 900cr in 3yrs
Everything from int accruals👌

Splty chem-550cr
Nutrition n health-100cr
Lifescience chem-250cr

Fy22 capex-350cr
Rev potential-900cr @ peak capacity

Diketene-Oct commissioning
CDMO-Apr 2022
Vitamin B3+acetic anhydride

Key Technical Tools I found useful for day trading !!!

1. VWAP.
2. Pivot Points.
3. 20-100 ema.
4. Reference pts PDH-PDL.
5. Candlestick patterns.

(Time frame 5 mins)

#trading #Investment #StockMarket #Nifty

This is in response to the question by @unseenvalue

If I had to buy 1 stock today, anywhere in the world, no avg. up or down, 5 year holding period (I will make that as 10 year for thesis to play out)

Since I track mainly Indian equities, restricting the choice to this space

Few points to look for
1. Strong macro tailwind rather than headwind, huge growth runway for company/segment. It can't be in a niche space & demand must not be easily substitutable
2. Strong Biz Model, high growth curve (15%+ over the period), strong ROE profile (hurdle rate 20%)

3. Low or no leverage, efficient capital allocation, (read minimal or zero fresh dilution requirements), strong cash flows and correspondingly high dividend payout ratios (consistent dividend history) and finally strong moat and with limited regulatory involvement / no reg issues

4. Promoter quality and intention must be beyond reproach, proven management with skin in the game
5. Capability to manage disruption, and if possible to even profit from it. If you can't be disrupted easily, you will eventually adapt your game to gain scale

6. There must be a possibility of non-linear growth if the scale-up hypothesis gets proven right. It's like an FD with low fixed return plus significant upside optionality. Multiple revenue streams / margin levers / IP that can provide non linearity in growth